These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9669494)

  • 1. Quinpirole attenuates striatal c-fos induction by 5-HT, opioid and muscarinic receptor agonists.
    Cook DF; Wirtshafter D
    Eur J Pharmacol; 1998 May; 349(1):41-7. PubMed ID: 9669494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinpirole attenuates the striatal immediate early gene expression, but not the hyperactivity, induced by the serotonin agonist RU-24969.
    Cook DF; Wirtshafter D
    Brain Res; 2000 Jan; 852(2):247-54. PubMed ID: 10678749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Turgeon SM; Fink JS
    Neuroscience; 1997 Jul; 79(1):79-93. PubMed ID: 9178866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinpirole attenuates the striatal fos expression induced by escape behavior.
    Struthers WM; Wirtshafter D
    Brain Res; 1998 Mar; 785(2):347-50. PubMed ID: 9518687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of scopolamine and quinpirole on the striatal fos expression induced by stimulation of D(1) dopamine receptors in the rat.
    Wirtshafter D; Asin KE
    Brain Res; 2001 Mar; 893(1-2):202-14. PubMed ID: 11223008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Fos identification of neuroanatomical sites associated with haloperidol and clozapine disruption of maternal behavior in the rat.
    Zhao C; Li M
    Neuroscience; 2010 Apr; 166(4):1043-55. PubMed ID: 20096751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time dependence and role of N-methyl-D-aspartate glutamate receptors in the priming of D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
    Pollack AE; Strauss JB
    Brain Res; 1999 May; 827(1-2):160-8. PubMed ID: 10320705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.
    LaHoste GJ; Yu J; Marshall JF
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7451-5. PubMed ID: 8102797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine and serotonin interactions in the modulation of the expression of the immediate-early transcription factor, nerve growth factor-inducible B, in the striatum.
    Gervais J; Soghomonian JJ; Richard D; Rouillard C
    Neuroscience; 1999; 91(3):1045-54. PubMed ID: 10391482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
    Pollack AE; Thomas LI
    Pharmacol Biochem Behav; 2010 Jan; 94(3):346-51. PubMed ID: 19800912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fenfluramine-induced activation of the immediate-early gene c-fos in the striatum: possible interaction between serotonin and dopamine.
    Rouillard C; Bovetto S; Gervais J; Richard D
    Brain Res Mol Brain Res; 1996 Apr; 37(1-2):105-15. PubMed ID: 8738141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin-1B agonists induce compartmentally organized striatal Fos expression in rats.
    Wirtshafter D; Cook DF
    Neuroreport; 1998 Apr; 9(6):1217-21. PubMed ID: 9601697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic receptor blockade attenuates reserpine-mediated Fos induction in the rat striatopallidal pathway.
    Pollack AE; Angerer MR
    Brain Res; 2005 Oct; 1058(1-2):189-92. PubMed ID: 16153612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Subset of Purposeless Oral Movements Triggered by Dopaminergic Agonists Is Modulated by 5-HT
    Lagière M; Bosc M; Whitestone S; Benazzouz A; Chagraoui A; Millan MJ; De Deurwaerdère P
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotation and striatal c-fos expression after repeated, daily treatment with selective dopamine receptor agonists and levodopa.
    Asin KE; Bednarz L; Nikkel A; Perner R
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1483-90. PubMed ID: 7791123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP).
    Callahan PM; Cunningham KA
    Eur J Pharmacol; 1994 May; 257(1-2):27-38. PubMed ID: 8082704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of striatal dopamine release through 5-HT1 and 5-HT2 receptors.
    Ng NK; Lee HS; Wong PT
    J Neurosci Res; 1999 Mar; 55(5):600-7. PubMed ID: 10082082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The selective m1 muscarinic antagonist MT-7 blocks pilocarpine-induced striatal Fos expression.
    Wirtshafter D
    Brain Res; 2006 Apr; 1085(1):127-31. PubMed ID: 16564505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compartmentally specific effects of quinpirole on the striatal Fos expression induced by stimulation of D1-dopamine receptors in intact rats.
    Wirtshafter D; Schardt G; Asin KE
    Brain Res; 1997 Oct; 771(2):271-7. PubMed ID: 9401747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.